The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $14.90

Today's change0.00 0.00%
Updated October 20 4:01 PM EDT. Delayed by at least 15 minutes.
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $14.90

Today's change0.00 0.00%
Updated October 20 4:01 PM EDT. Delayed by at least 15 minutes.

Teva Pharmaceutical Industries Ltd closed at (U.S.)$14.90.

Over the last five days, shares have lost 0.53% and sit 4.20% above their 52-week low. This security has underperformed the S&P 500 by 86.56% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $14.90
  • High--
  • Low--
  • Bid / Ask(U.S.) $14.96 / (U.S.) $14.97
  • YTD % change-58.90%
  • Volume12,947
  • Average volume (10-day)16,486,457
  • Average volume (1-month)23,928,475
  • Average volume (3-month)19,376,761
  • 52-week range(U.S.) $14.30 to (U.S.) $44.42
  • Beta0.54
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward3.51×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.11
  • Dividend yield7.42%
  • Trailing EPS(U.S.) -$6.03
Updated October 20 4:01 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue5,6865,6306,4925,563
Total other revenue--------
Total revenue5,6865,6306,4925,563
Gross profit2,8212,8193,3902,801
Total cost of revenue2,8652,8113,1022,762
Total operating expense11,4284,7356,6294,798
Selling / general / administrative1,2321,2071,4401,250
Research & development486457684663
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)6,8422051,508720
Other operating expenses, total33-105-597
Operating income-5,742895-137765
Interest income (expense), net non-operating-151-151----
Gain (loss) on sale of assets--------
Other--------
Income before tax-5,978688-914615
Income after tax-5,956634-971408
Income tax, total-225457207
Net income-5,970645-973412
Total adjustments to net income-65-65-65-64
Net income before extra. items-5,970645-973412
Minority interest0412
Equity in affiliates-147-32
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6,035580-1,038348
Inc. avail. to common incl. extra. items-6,035580-1,038348
Diluted net income-6,035580-1,038348
Dilution adjustment--000
Diluted weighted average shares1,0171,0171,015984
Diluted EPS excluding extraordinary itemsvalue per share-5.930.57-1.020.35
Dividends per sharevalue per share0.340.340.340.34
Diluted normalized EPSvalue per share-1.560.76-0.060.84